Tectin (drug)
Tectin is the brand name of a pain killing drug currently in development by WEX Pharmaceuticals Inc. The drug comes from a toxin in the pufferfish called tetrodotoxin, a very potent neurotoxin which shuts down electrical signaling in nerves by binding to the pores of sodium channel proteins in nerve cell membranes.
Tectin holds promise to relieve severe pain when other standard pain relievers are found to be ineffective. It is also being researched as a drug to relieve the symptoms of withdrawal in opiate addicts. The drug showed promising results in Canadian phase IIa clinical trials for the treatment of cancer related pain.[1] However interim results from the phase IIb/III clinical trial where the drug did not meet the primary efficacy goal has led to the termination of this trial.[2]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />External links
- "WEX Pharmaceuticals Inc. Company Site". Retrieved 2008-05-02.
| 40x30px | This product article is a stub. You can help ssf by expanding it. |
